Mini-review: the neurobiology of treating substance use disorders with classical psychedelics

MM Urban, MR Stingl, MW Meinhardt - Frontiers in Neuroscience, 2023 - frontiersin.org
The potential of psychedelics to persistently treat substance use disorders is known since
the 1960s. However, the biological mechanisms responsible for their therapeutic effects …

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges

LM Salinsky, CR Merritt, JC Zamora… - Frontiers in …, 2023 - frontiersin.org
Opioid misuse and opioid-involved overdose deaths are a massive public health problem
involving the intertwined misuse of prescription opioids for pain management with the …

Psychiatric risks for worsened mental health after psychedelic use

A Marrocu, H Kettner, B Weiss… - Journal of …, 2024 - journals.sagepub.com
Background: Resurgent psychedelic research has largely supported the safety and efficacy
of psychedelic therapy for the treatment of various psychiatric disorders. As psychedelic use …

Psychedelics and workplace harm

SM Viña, AL Stephens - Frontiers in Psychiatry, 2023 - frontiersin.org
This study aims to understand the relationship between Lifetime Classic Psychedelic Use
(LCPU), employment status, and weekly work hours on levels of psychological distress. The …

Religion, psychedelics, risky behavior, and violence

SM Viña - Journal of psychoactive drugs, 2024 - Taylor & Francis
Research has found that psychedelic use is associated with positive behavioral changes,
however research has yet to explore the relationship between socio-cultural conditions on …

Converging theories on dreaming: Between Freud, predictive processing, and psychedelic research

M Koslowski, MP de Haas, T Fischmann - Frontiers in Human …, 2023 - frontiersin.org
Dreams are still an enigma of human cognition, studied extensively in psychoanalysis and
neuroscience. According to the Freudian dream theory and Solms' modifications of the …

Weiterbildung in Psychedelika-assistierter Therapie–Erfahrungen aus der Schweiz

HD Aicher, P Gasser - Die Psychotherapie, 2024 - Springer
Zusammenfassung Erste Studienergebnisse zeigen ein Potenzial von Psychedelika und 3,
4-Methylendioxy-N-methylamphetamin (MDMA) für die Behandlung von affektiven …

[HTML][HTML] Novel extended-release transdermal formulations of the psychedelic N, N-dimethyltryptamine (DMT)

CG Witowski, MR Hess, NT Jones, MCP Hahn… - European Journal of …, 2024 - Elsevier
There is considerable evidence from the literature that psychedelics, such as N, N-
dimethyltryptamine (DMT), are safe and effective treatments for depression. However …

Psychotherapeutic Interventions in Clinical Trials of Psychedelics for the Treatment of Alcohol Use Disorder

A Mohammad Aghaei, J Weleff, B Martins, K Ing… - Current Addiction …, 2024 - Springer
Abstract Purpose of Review Alcohol use disorder (AUD) is the most common substance use
disorder in the USA, with a considerable burden of disease. In recent years, psychedelics …

Psychedelika-assistierte Psychotherapie

HD Aicher, Y Schmid, P Gasser - Die Psychotherapie, 2024 - Springer
Seit den späten 1990er-Jahren erfahren Psychedelika eine Renaissance und ziehen
international vermehrt die Aufmerksamkeit auf sich. Es gibt zunehmend wissenschaftliche …